Yael I Nillni1,2, Ann M Rasmusson3,4, Emilie L Paul5, Suzanne L Pineles3,4. 1. National Center for PTSD, Women's Health Sciences Division at VA Boston Healthcare System, 150 South Huntington Ave. (116B-3), Boston, MA, 02130, USA. ynillni@bu.edu. 2. Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA. ynillni@bu.edu. 3. National Center for PTSD, Women's Health Sciences Division at VA Boston Healthcare System, 150 South Huntington Ave. (116B-3), Boston, MA, 02130, USA. 4. Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA. 5. Department of Psychiatry, Boston Medical Center, Boston, MA, USA.
Abstract
PURPOSE OF REVIEW: This paper reviews the recent literature on menstrual cycle phase effects on outcomes relevant to anxiety and PTSD, discusses potential neurobiological mechanisms underlying these effects, and highlights methodological limitations impeding scientific advancement. RECENT FINDINGS: The menstrual cycle and its underlying hormones impact symptom expression among women with anxiety and PTSD, as well as psychophysiological and biological processes relevant to anxiety and PTSD. The most consistent findings are retrospective self-report of premenstrual exacerbation of anxiety symptoms and the protective effect of estradiol on recall of extinction learning among healthy women. Lack of rigorous methodology for assessing menstrual cycle phase and inconsistent menstrual cycle phase definitions likely contribute to other conflicting results. Further investigations that address these limitations and integrate complex interactions between menstrual cycle phase-related hormones, genetics, and psychological vulnerabilities are needed to inform personalized prevention and intervention efforts for women.
PURPOSE OF REVIEW: This paper reviews the recent literature on menstrual cycle phase effects on outcomes relevant to anxiety and PTSD, discusses potential neurobiological mechanisms underlying these effects, and highlights methodological limitations impeding scientific advancement. RECENT FINDINGS: The menstrual cycle and its underlying hormones impact symptom expression among women with anxiety and PTSD, as well as psychophysiological and biological processes relevant to anxiety and PTSD. The most consistent findings are retrospective self-report of premenstrual exacerbation of anxiety symptoms and the protective effect of estradiol on recall of extinction learning among healthy women. Lack of rigorous methodology for assessing menstrual cycle phase and inconsistent menstrual cycle phase definitions likely contribute to other conflicting results. Further investigations that address these limitations and integrate complex interactions between menstrual cycle phase-related hormones, genetics, and psychological vulnerabilities are needed to inform personalized prevention and intervention efforts for women.
Authors: Simon Vermeire; Kurt Audenaert; Rudy De Meester; Eva Vandermeulen; Tim Waelbers; Bart De Spiegeleer; Jos Eersels; André Dobbeleir; Kathelijne Peremans Journal: Res Vet Sci Date: 2010-11-03 Impact factor: 2.534
Authors: Ann M Rasmusson; Graziano Pinna; Prashni Paliwal; David Weisman; Christopher Gottschalk; Dennis Charney; John Krystal; Alessandro Guidotti Journal: Biol Psychiatry Date: 2006-08-24 Impact factor: 13.382
Authors: Eva Montero-López; Ana Santos-Ruiz; M Carmen García-Ríos; Manuel Rodríguez-Blázquez; Heather L Rogers; María Isabel Peralta-Ramírez Journal: Int J Psychophysiol Date: 2018-03-29 Impact factor: 2.997
Authors: Zhenfu Wen; Mira Z Hammoud; J Cobb Scott; Jagan Jimmy; Lily Brown; Marie-France Marin; Anu Asnaani; Ruben C Gur; Edna B Foa; Mohammed R Milad Journal: Neuropsychopharmacology Date: 2021-09-07 Impact factor: 7.853